Is CYP2C19 useful for Haut?

CYP2C19 is a cytochrome P450 enzyme primarily involved in drug metabolism (e.g., omeprazole, clopidogrel, certain antidepressants). There is no direct, well-established evidence linking CYP2C19 variants to skin health, skin aging, or dermatological conditions. The enzyme may be indirectly relevant if medications metabolized by CYP2C19 are used for skin issues – for example, proton pump inhibitors for rosacea or antidepressants for pruritus. However, these effects are small and not robustly supported. Consumer DNA tests that include CYP2C19 do not provide clinically actionable insights for skin. For skin-related concerns, validated biomarkers (e.g., vitamin D, ferritin) or a dermatologist’s evaluation are more appropriate. Evidence: unclear. Safety note: CYP2C19 genotyping should never be used for medication decisions without physician guidance.